You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
DeCode's new offering adds to an ongoing controversy over whether people in the island country have a right to know if they are at increased risk for disease.
HHS may already be administering DNA testing to migrant families, but the agency has provided little information about how testing is being implemented.
Researchers at Columbia University and CHOP believe they can shorten time to diagnosis and improve yield by extracting phenotypic data from EHRs for genomic labs.
The company plans to use the new funding to grow its suite of genomics applications to more than 50 in 2018.
The company outlined its plans to launch a kidney transplant rejection test that is based on cell-free DNA in 2019 and described its progress in breast cancer research.
The court's ruling that Quest was acting as a licensed healthcare provider could affect the statute of limitations in the suit.
The companies have launched a center that offers consulting and management specifically for genomically targeted or precision medicine trials.
The new assay simultaneously detects four viral targets in donated blood plasma in a single sample and can add value to the biologics development space.
On the heels of the WINTHER study, the consortium has planned a new trial called MERCURY, and will launch a blood and tissue repository.
The subcommittee called for $2 billion to be added to the NIH's budget next year, increasing it to $39.1 billion.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.